Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of “Hold” from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have issued a buy recommendation on the company. […]
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have issued a buy recommendation on the company. […]
